Ascendis Pharma A/S stockASND
Ascendis Pharma A/S trades at $253.45, 10.2% below its 52-week high (Jul 9, 2026). The price is above its 50- and 200-day averages, i.e. in an uptrend. +18.9% year to date, +28.2% over 12 months (S&P 500 over the same period: +8.8%). Next earnings report: Nov 11, 2026.
Ratings, candles, signals and the screener for ASND — after you log in
Open the terminalFrequently asked questions about Ascendis Pharma A/S
What is the Ascendis Pharma A/S stock price?
At the close on Nov 5, 2026: $253.45 (−1.74% on the day). 52-week high: $282.15 on Jul 9, 2026. During the session the price is updated with a 15-minute delay, after the close with the day's final figures.
When does Ascendis Pharma A/S report earnings?
The next quarterly report is on Nov 11, 2026. Last quarter, earnings per share changed +445% year over year, revenue +114%.
Does Ascendis Pharma A/S pay dividends?
No, Ascendis Pharma A/S does not pay dividends.
Where does Ascendis Pharma A/S trade and how to buy it?
Ticker ASND, exchange Nasdaq, listed since 2015. You can buy it through a broker with access to US exchanges.
Should I buy Ascendis Pharma A/S now?
We do not give buy or sell advice. Ratings, the detailed chart and signals for ASND are in the terminal after you log in.